Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy

Total article views   HTML views PDF downloads Totals
3,012 Dovepress* 2,752+ 804 3,556
PubMed Central* 260 83 343
Totals 3,012 887 3,899
*Since 29 October 2020

View citations on PubMed Central and Google Scholar